Applied Therapeutics Forum: Community User: Reevo90
Applied Therapeutics (Nasdaq: APLT) agreed to be acquired by Cycle Group Holdings for $0.088 per share cash plus one non-transferrable contingent value right (CVR). The CVR can pay up to $0.10 for FDA approval in a galactosemia indication, $0.10 for FDA approval in CMT-SORD, and $0.20 upon first worldwide net sales ≥ $200M in any four-quarter period; CVR holders also share in a capped Closing Cash Payment tied to Applied cash above $500,000 (capped at $1.5M). The tender offer is expected to close in Q1 2026; the merger has no financing condition. Applied received an unsecured promissory note enabling up to $8.5M in loans to fund working capital.
|
|
Thema | ||
|---|---|---|---|
| 1 | NVIDIA Hauptdiskussion | +3,90 % | |
| 2 | BioNTech Hauptdiskussion | +0,51 % | |
| 3 | NEL ohne Spam | +0,67 % | |
| 4 | Critical Metals: Grönland - Tanbreez seltene Erden | ±0,00 % | |
| 5 | Pyrum Innovations | +0,40 % | |
| 6 | Vulcan Energy Resources Hauptdiskussion | ±0,00 % | |
| 7 | Volatus Aerospace (Offener Austausch) | -5,38 % | |
| 8 | MICROSTRATEGY Hauptdiskussion | +11,23 % | |
| 9 | US Tech 100 Hauptdiskussion | -5,83 % | |
| 10 | Austausch zur Aktie von Thungela Resources | +0,17 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | NVIDIA Hauptdiskussion | +3,90 % | |
| 2 | BioNTech Hauptdiskussion | +0,51 % | |
| 3 | NEL ohne Spam | +0,67 % | |
| 4 | Critical Metals: Grönland - Tanbreez seltene Erden | ±0,00 % | |
| 5 | Pyrum Innovations | +0,40 % | |
| 6 | Vulcan Energy Resources Hauptdiskussion | ±0,00 % | |
| 7 | Volatus Aerospace (Offener Austausch) | -5,38 % | |
| 8 | MICROSTRATEGY Hauptdiskussion | +11,23 % | |
| 9 | Austausch zur Aktie von Thungela Resources | +0,17 % | |
| 10 | Almonty Das freie Forum | +0,80 % | Alle Diskussionen |